Clark Financial Services Group Inc Bristol Myers Squibb CO Transaction History

Clark Financial Services Group Inc

$83 Million
Q1 2024

A detailed history of Clark Financial Services Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clark Financial Services Group Inc holds 6,097 shares of BMY stock, worth $246,623. This represents 0.4% of its overall portfolio holdings.

Number of Shares

6,097

Previous 6,265 2.68%

Holding current value

$246,623

Previous $321,000 2.8%

% of portfolio

0.4%

Previous 0.41%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $8,060 - $9,139	-168 Reduced 2.68%	6,097 $330,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $1,599 - $1,909	-33 Reduced 0.52%	6,265 $321,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $5,731 - $6,408	-99 Reduced 1.55%	6,298 $365,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $318 - $353	-5 Reduced 0.08%	6,397 $409,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $5,125 - $5,813	78 Added 1.23%	6,402 $444,000

Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $4,930 - $5,838	72 Added 1.15%	6,324 $454,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $4 - $2,535	33 Added 0.53%	6,252 $444,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $6,516 - $7,814	106 Added 1.73%	6,219 $455,000
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $7,293 - $8,502	-136 Reduced 2.18%	6,113 $381,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $83,311 - $97,588	1,408 Added 29.08%	6,249 $369,000
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $11,639 - $12,674	188 Added 4.04%	4,841 $323,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $93,994 - $105,716	-1,584 Reduced 25.4%	4,653 $294,000
Q2 2020 Aug 12, 2022	BUY	$54.82 - $64.09 $341,912 - $399,729	6,237 New	6,237 $481,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Financial Services Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Clark Financial Services Group Inc with notifications on news.

Account

Clark Financial Services Group Inc Bristol Myers Squibb CO Transaction History